Additionally, Krit et al. reported that the combined use of dapagliflozin and Metformin exerts synergistic benefits in DN in rats, including reductions in oxidative stress, inflammation, and apoptosis, alongside enhanced autophagy through modulation of the AMPK/mTOR/SIRT1 axis (39). The gene discussed is MTOR; the disease is liver dysplastic nodule.